Clinical Trial Update: Correct Use of Sequential Formoterol and Budesonide Inhaler Capsule Treatment Via Aerolizer and Patient Satisfaction in Asthmatics [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating sequential use of formoterol and budesonide via Aerolizer in asthmatics has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide (BUDESONIDE)
• Formoterol (formoterol)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 4 | Status: WITHDRAWN